New Guideline on Diabetes-Related Hypoglycemia Management Released
Endocrine Society Clinical Practice Guideline examines better ways to manage hypoglycemia in people with diabetes.
Diagnosis & Disease Information
FDA Clears Smartphone App for Insulin Delivery
The updated t:connect mobile app is the first-ever FDA-cleared smartphone application capable of initiating insulin delivery via iOS and Android operating systems.
The Relationship Between Depression, Distress, and Diabetes
In addition to cardiac and other well-known physical comorbities, depression can add a serious complexity in people with type 1 and type 2 diabetes.
Insulin Prescriptions Fell for Type 2 Diabetes During Height of COVID-19
Insulin prescriptions fell during the COVID-19 pandemic for adults with type 2 diabetes. Children with type 1 diabetes were much less affected.
Biologic for Type 2 Diabetes May Offer More Glycemic Control, Weight Loss Than Insulin
An experimental, injectable drug for type 2 diabetes may be superior to insulin for both glycemic and weight control.
Postexercise Recovery for Endurance Athletes With Type 1 Diabetes: Consensus Statement
To understand the requirements of individuals with T1D in a population of endurance or high-performing athletes, it is crucial to understand the physiologic mechanisms that occur following exercise.
New Rapid-Acting Insulin Lispro Approved by FDA
The FDA has approved Lyumjev™ (insulin lispro-aabc injection; Lilly) to improve glycemic control in adults with type 1 and type 2 diabetes.
FDA Approves Long-Acting Insulin Glargine Injection for T1D, T2D
The FDA has approved Semglee™ (insulin glargine injection; Mylan and Biocon) to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.
Insulin Needle Reuse Leads to Serious Fungal Infection in Immunocompromised Patient
After obtaining a more detailed history, it was discovered that the patient had been reusing insulin needles and was not rotating sites for insulin injection.
Coffee Consumption Does Not Affect Insulin Sensitivity
Consumption of four cups of coffee daily does not impact insulin sensitivity, according to a study published in the American Journal of Clinical Nutrition.
- Loading...
Loading...
Next post in News
Loading... 
Loading...